Topical Azole Therapy for Uncomplicated Vaginal Candidiasis

First‑Line Regimens for Non‑Pregnant Women

The CDC recommends short‑course topical azole therapy (e.g., clotrimazole 1 % cream 5 g for 7–14 days, miconazole 2 % cream 5 g for 7 days, or a single‑dose clotrimazole 500 mg vaginal tablet) as the preferred treatment for uncomplicated yeast vaginitis. 1
Short‑course (1–3 day) topical azole regimens are as effective as longer courses, achieving cure rates of 80–90 % in uncomplicated cases. 1
Over‑the‑counter clotrimazole 1 % cream 5 g intravaginally for 7–14 days is an effective first‑line option. 1
A single‑dose clotrimazole 500 mg vaginal tablet provides cure rates comparable to oral azoles and has a long safety record with rare resistance. 1
Over‑the‑counter miconazole 2 % cream 5 g intravaginally for 7 days is an effective alternative. 1
Miconazole 200 mg vaginal suppository once daily for 3 days is also effective. 1
Tioconazole 6.5 % ointment 5 g given as a single intravaginal application is an effective OTC option. 1
Prescription‑only terconazole 0.4 % cream 5 g intravaginally for 7 days is an effective regimen. 1
Terconazole 0.8 % cream 5 g intravaginally for 3 days provides comparable efficacy. 1
Prescription butoconazole 2 % cream 5 g intravaginally for 3 days is an effective alternative. 1

Topical azoles are significantly more effective than nystatin, which should be avoided as first‑line therapy. (Strong evidence) 1

The CDC (via Praxis 2026) advises that pregnant women receive only 7‑day topical azole regimens; oral fluconazole is contraindicated. (High‑quality recommendation) 2
Recommended 7‑day pregnancy regimens include:
Seven‑day courses are more effective than shorter regimens in pregnancy. (Moderate evidence) 2

Diagnosis requires typical symptoms (pruritus, white discharge, vulvar erythema) plus either a wet‑mount showing yeasts/pseudohyphae or a positive culture. (Strong evidence) 1
Vaginal pH remains normal (< 4.5) in candidal vaginitis, helping to differentiate from bacterial vaginosis. 1
Adding 10 % potassium hydroxide to wet preparations improves visualization of yeast and mycelia. 1
Asymptomatic colonization is present in 10–20 % of women and does not require treatment. (Strong evidence) 1

Oil‑based creams and suppositories can weaken latex condoms and diaphragms; patients should be counseled to avoid concurrent use. (Strong evidence) 1
Self‑treatment with OTC preparations should be limited to women who have previously received a clinician’s diagnosis and who experience identical recurrent symptoms. (Strong evidence) 1
Persistent symptoms after OTC therapy or recurrence within 2 months warrants medical re‑evaluation. (Strong evidence) 1

For severe or complicated vulvovaginal candidiasis, a 7‑day topical azole regimen is preferred over single‑dose options. (Evidence from Praxis 2026) 3